249 related articles for article (PubMed ID: 31420057)
1. Effects of oral Nigella sativa oil on the expression levels and serum concentrations of adiponectin, PPAR-γ, and TNF-α in overweight and obese women: a study protocol for a crossover-designed, double-blind, placebo-controlled randomized clinical trial.
Razmpoosh E; Safi S; Mazaheri M; Salehi-Abargouei A; Abdollahi N; Nazari M; Fallahzadeh H; Nadjarzadeh A
Trials; 2019 Aug; 20(1):512. PubMed ID: 31420057
[TBL] [Abstract][Full Text] [Related]
2. Nigella sativa oil with a calorie-restricted diet can improve biomarkers of systemic inflammation in obese women: A randomized double-blind, placebo-controlled clinical trial.
Mahdavi R; Namazi N; Alizadeh M; Farajnia S
J Clin Lipidol; 2016; 10(5):1203-11. PubMed ID: 27678438
[TBL] [Abstract][Full Text] [Related]
3. Effects of
Razmpoosh E; Safi S; Nadjarzadeh A; Salehi-Abargouei A; Mazaheri M; Mirmiran P; Meyre D
Br J Nutr; 2022 May; ():1-10. PubMed ID: 35538630
[TBL] [Abstract][Full Text] [Related]
4. The effect of Nigella sativa supplementation on cardiovascular risk factors in obese and overweight women: a crossover, double-blind, placebo-controlled randomized clinical trial.
Razmpoosh E; Safi S; Nadjarzadeh A; Fallahzadeh H; Abdollahi N; Mazaheri M; Nazari M; Salehi-Abargouei A
Eur J Nutr; 2021 Jun; 60(4):1863-1874. PubMed ID: 32876804
[TBL] [Abstract][Full Text] [Related]
5. The effect of Nigella sativa on appetite, anthropometric and body composition indices among overweight and obese women: A crossover, double-blind, placebo-controlled, randomized clinical trial.
Safi S; Razmpoosh E; Fallahzadeh H; Mazaheri M; Abdollahi N; Nazari M; Nadjarzadeh A; Salehi-Abargouei A
Complement Ther Med; 2021 Mar; 57():102653. PubMed ID: 33370571
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of yellow pea fibre supplementation on weight loss and the gut microbiota: a randomized controlled trial.
Lambert JE; Parnell JA; Han J; Sturzenegger T; Paul HA; Vogel HJ; Reimer RA
BMC Gastroenterol; 2014 Apr; 14():69. PubMed ID: 24712378
[TBL] [Abstract][Full Text] [Related]
7. Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial.
Naeini F; Namkhah Z; Tutunchi H; Rezayat SM; Mansouri S; Jazayeri-Tehrani SA; Yaseri M; Hosseinzadeh-Attar MJ
Trials; 2021 Nov; 22(1):801. PubMed ID: 34774104
[TBL] [Abstract][Full Text] [Related]
8. No effects of quercetin from onion skin extract on serum leptin and adiponectin concentrations in overweight-to-obese patients with (pre-)hypertension: a randomized double-blinded, placebo-controlled crossover trial.
Brüll V; Burak C; Stoffel-Wagner B; Wolffram S; Nickenig G; Müller C; Langguth P; Alteheld B; Fimmers R; Stehle P; Egert S
Eur J Nutr; 2017 Oct; 56(7):2265-2275. PubMed ID: 27423432
[TBL] [Abstract][Full Text] [Related]
9. Effects of Nigella sativa oil with a low-calorie diet on cardiometabolic risk factors in obese women: a randomized controlled clinical trial.
Mahdavi R; Namazi N; Alizadeh M; Farajnia S
Food Funct; 2015 Jun; 6(6):2041-8. PubMed ID: 26029855
[TBL] [Abstract][Full Text] [Related]
10. Oxidative Stress Responses to Nigella sativa Oil Concurrent with a Low-Calorie Diet in Obese Women: A Randomized, Double-Blind Controlled Clinical Trial.
Namazi N; Mahdavi R; Alizadeh M; Farajnia S
Phytother Res; 2015 Nov; 29(11):1722-8. PubMed ID: 26179113
[TBL] [Abstract][Full Text] [Related]
11. Effects of synbiotic supplementation on gut microbiome, serum level of TNF-α, and expression of microRNA-126 and microRNA-146a in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomized clinical trial.
Zeinali F; Aghaei Zarch SM; Vahidi Mehrjardi MY; Kalantar SM; Jahan-Mihan A; Karimi-Nazari E; Fallahzadeh H; Hosseinzadeh-Shamsi-Anar M; Rahmanian M; Fazeli MR; Mozaffari-Khosravi H
Trials; 2020 Apr; 21(1):324. PubMed ID: 32290852
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the effect of curcumin and zinc co-supplementation on glycemic measurements, lipid profiles, and inflammatory and antioxidant biomarkers in overweight or obese prediabetic patients: a study protocol for a randomized double-blind placebo-controlled phase 2 clinical trial.
Karandish M; Mozaffari-Khosravi H; Mohammadi SM; Azhdari M; Cheraghian B
Trials; 2020 Nov; 21(1):991. PubMed ID: 33256795
[TBL] [Abstract][Full Text] [Related]
13. Effects of synbiotic supplementation on serum adiponectin and inflammation status of overweight and obese breast cancer survivors: a randomized, triple-blind, placebo-controlled trial.
Raji Lahiji M; Zarrati M; Najafi S; Yazdani B; Cheshmazar E; Razmpoosh E; Janani L; Raji Lahiji M; Shidfar F
Support Care Cancer; 2021 Jul; 29(7):4147-4157. PubMed ID: 33404812
[TBL] [Abstract][Full Text] [Related]
14. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation.
Ngondi JL; Etoundi BC; Nyangono CB; Mbofung CM; Oben JE
Lipids Health Dis; 2009 Mar; 8():7. PubMed ID: 19254366
[TBL] [Abstract][Full Text] [Related]
15. The effect of nigella sativa supplementation on cardiometabolic outcomes in patients with non-alcoholic fatty liver: A randomized double-blind, placebo-controlled trial.
Rashidmayvan M; Vandyousefi S; Barati M; Salamat S; Ghodrat S; Khorasanchi M; Jahan-Mihan A; Nattagh-Eshtivani E; Mohammadshahi M
Complement Ther Clin Pract; 2022 Aug; 48():101598. PubMed ID: 35567872
[TBL] [Abstract][Full Text] [Related]
16. Effects of probiotic yogurt on fat distribution and gene expression of proinflammatory factors in peripheral blood mononuclear cells in overweight and obese people with or without weight-loss diet.
Zarrati M; Salehi E; Nourijelyani K; Mofid V; Zadeh MJ; Najafi F; Ghaflati Z; Bidad K; Chamari M; Karimi M; Shidfar F
J Am Coll Nutr; 2014; 33(6):417-25. PubMed ID: 25079040
[TBL] [Abstract][Full Text] [Related]
17. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Greenway FL; Fujioka K; Plodkowski RA; Mudaliar S; Guttadauria M; Erickson J; Kim DD; Dunayevich E;
Lancet; 2010 Aug; 376(9741):595-605. PubMed ID: 20673995
[TBL] [Abstract][Full Text] [Related]
18. Yeast β-Glucan Modulates Inflammation and Waist Circumference in Overweight and Obese Subjects.
Mosikanon K; Arthan D; Kettawan A; Tungtrongchitr R; Prangthip P
J Diet Suppl; 2017 Mar; 14(2):173-185. PubMed ID: 27715351
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of HT048 and HT077 for body fat and weight loss in overweight adults: A study protocol for a double-blind, randomized, placebo-controlled trial.
Song J; Shin SM; Kim H
Medicine (Baltimore); 2019 Nov; 98(45):e17922. PubMed ID: 31702673
[TBL] [Abstract][Full Text] [Related]
20. A Fraxinus excelsior L. seeds/fruits extract benefits glucose homeostasis and adiposity related markers in elderly overweight/obese subjects: a longitudinal, randomized, crossover, double-blind, placebo-controlled nutritional intervention study.
Zulet MA; Navas-Carretero S; Lara y Sánchez D; Abete I; Flanagan J; Issaly N; Fança-Berthon P; Bily A; Roller M; Martinez JA
Phytomedicine; 2014 Sep; 21(10):1162-9. PubMed ID: 24877717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
